Regeneron (REGN), Sanofi (SNY) Announce Significant Results from Praluent Phase 3 in HeFH Patients
Tweet Send to a Friend
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and Sanofi (NYSE: SNY) announced detailed positive results from ODYSSEY ESCAPE, a Phase 3 trial ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
